UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand

Oncotarget, 2015, Vol.6 (1), p.288-304

2015

Link zum Volltext

Verfügbarkeit prüfen

Familial liability to asthma and ADHD: A Swedish national register‐based study

JCPP advances, 2021-12, Vol.1 (4), p.e12044-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer

Neoplasia (New York, N.Y.), 2013-09, Vol.15 (9), p.1009-IN3

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1209: Comprehensive in vitro characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal domain inhibitor

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1209-1209

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P192: Comprehensive preclinical characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal domain inhibitor

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P192-P192

2021

Link zum Volltext

Verfügbarkeit prüfen

Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes: From Association to Prevention

Sun, Shihua

2020

Link zum Volltext
ProQuest

Random access conflict resolution of preamble waiting list based Game-theory

Journal of physics. Conference series, 2021-05, Vol.1920 (1), p.12085

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5643: Physical and functional interactions of exon-skipping variants of androgen receptor with the full-length counterpart

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5643-5643

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1194: Neutralization of IGF-I and -II ligands with the fully humanized bispecific monoclonal antibody xentuzumab inhibits AR-V7-induced enzalutamide resistance in castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1194-1194

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3837: Bumped kinase inhibitor 1553 selectively inhibits androgen receptor positive prostate cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3837-3837

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5159: Identification of ARv567es expression profile in the prostate cancer clinical samples with a newly developed antibody

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5159-5159

2015

Link zum Volltext

Verfügbarkeit prüfen

Family co-aggregation of asthma and ADHD: a Swedish register-based study

BEHAVIOR GENETICS, 2019, Vol.49 (6), p.512

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2114: UGT2B17 is a unique co-regulator of the androgen receptor and androgen receptor splice variants in prostate cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2114-2114

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4676: In silico and in vitro analyses of androgen receptor splicing variants with a special focus on human patient samples

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4676-4676

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4965: Analytic validation and clinical qualification of a novel immunohistochemical assay for AR-V7 protein expression in metastatic prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4965-4965

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR015: Inhibition of androgen receptor signaling in castrate resistant prostate cancer in association with inhibition of glycolysis by targeting hexokinase 2 activity with pyrrolopyrimidine-based small molecules

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.PR015-PR015

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2324: Phospho-MED1 mediates the transcriptional regulation of AR splice variants in castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2324-2324

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 311: AR splice variant, ARv567es, enhances proliferation and induces tumor formation in a novel transgenic mouse model of prostate cancer, Pb-ARv567es

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.311-311

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4082: Mechanisms of androgen receptor splicing in prostate cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4082-4082

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract B11: Loss of the androgen receptor (AR) ligand-binding domain transforms the AR transcriptome in prostate cancer

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4_Supplement), p.B11-B11

2012

Link zum Volltext

Verfügbarkeit prüfen

AR Variant AR super(v567es) Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer

Neoplasia (New York, N.Y.), 2013-09, Vol.15 (9), p.1009-1017

2013

Link zum Volltext

Verfügbarkeit prüfen

AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer12

Neoplasia (New York, N.Y.), 2013-09, Vol.15 (9), p.1009-1017

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4537: Interaction with wild-type (wt) androgen receptor (AR) alters the function of AR splice-variants and response to AR-ligand binding domain inhibition

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4537-4537

2011

Link zum Volltext

Verfügbarkeit prüfen

Need for further analysis to explore the association between ADHD and asthma – Authors' reply

The Lancet. Psychiatry, 2018-12, Vol.5 (12), p.963-964

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 631: Androgen receptor(AR) splice variants inhibit responses to IGF-IR inhibition in prostate cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.631-631

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 162

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(14)
Observers
(8)
Animals
(7)
Simulation
(6)
Control Systems
(5)
Male
(5)
China
(4)
Disturbance Rejection
(4)
Disturbances
(4)
Extended State Observer
(4)
Female
(4)
Genetic Aspects
(4)
Nonlinear Systems
(4)
Output Feedback
(4)
Algorithms
(3)
Closed Loop Systems
(3)
Control Methods
(3)
Gene Expression
(3)
Heart Failure - Diagnostic Imaging
(3)
Heart Failure With Preserved Ejection Fraction
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand

Familial liability to asthma and ADHD: A Swedish national register‐based study

AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer

Abstract 1209: Comprehensive in vitro characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal domain inhibitor

Abstract P192: Comprehensive preclinical characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal domain inhibitor

Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes: From Association to Prevention

Random access conflict resolution of preamble waiting list based Game-theory

Abstract 5643: Physical and functional interactions of exon-skipping variants of androgen receptor with the full-length counterpart

Abstract 1194: Neutralization of IGF-I and -II ligands with the fully humanized bispecific monoclonal antibody xentuzumab inhibits AR-V7-induced enzalutamide resistance in castration-resistant prostate cancer

Abstract 3837: Bumped kinase inhibitor 1553 selectively inhibits androgen receptor positive prostate cancer

Abstract 5159: Identification of ARv567es expression profile in the prostate cancer clinical samples with a newly developed antibody

Family co-aggregation of asthma and ADHD: a Swedish register-based study

Abstract 2114: UGT2B17 is a unique co-regulator of the androgen receptor and androgen receptor splice variants in prostate cancer

Abstract 4676: In silico and in vitro analyses of androgen receptor splicing variants with a special focus on human patient samples

Abstract 4965: Analytic validation and clinical qualification of a novel immunohistochemical assay for AR-V7 protein expression in metastatic prostate cancer

Abstract PR015: Inhibition of androgen receptor signaling in castrate resistant prostate cancer in association with inhibition of glycolysis by targeting hexokinase 2 activity with pyrrolopyrimidine-based small molecules

Abstract 2324: Phospho-MED1 mediates the transcriptional regulation of AR splice variants in castration-resistant prostate cancer

Abstract 311: AR splice variant, ARv567es, enhances proliferation and induces tumor formation in a novel transgenic mouse model of prostate cancer, Pb-ARv567es

Abstract 4082: Mechanisms of androgen receptor splicing in prostate cancer cells

Abstract B11: Loss of the androgen receptor (AR) ligand-binding domain transforms the AR transcriptome in prostate cancer

AR Variant AR super(v567es) Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer

AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer12

Abstract 4537: Interaction with wild-type (wt) androgen receptor (AR) alters the function of AR splice-variants and response to AR-ligand binding domain inhibition

Need for further analysis to explore the association between ADHD and asthma – Authors' reply

Abstract 631: Androgen receptor(AR) splice variants inhibit responses to IGF-IR inhibition in prostate cancer

Aktive Filter

Suchergebnisse filtern